Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in

Medesis Pharma SA
PAR:ALMDP

Watchlist Manager
Medesis Pharma SA Logo
Medesis Pharma SA
PAR:ALMDP
Watchlist
Price: 0.35 EUR
Market Cap: €1.8m
Write Note Create Alert Ask AI

Medesis Pharma SA
Investor Relations

Medesis Pharma SA operates as a clinical development stage biopharmaceutical company. The company is headquartered in Baillargues, Occitanie. The company went IPO on 2021-02-12. The firm is engaged through its drug delivery technology Aonys in the development of orally administered molecule drug candidates to expand their therapeutic usefulness to address unmet medical needs. Its technology is also being used for collaborative research programs focused on oncology (customized cancer treatment) and radiotherapy (protection of healthy tissue). The Company’s two drug candidates for treating people contaminated following a civil or military nuclear accident are Plutonium decorporation and Cesium decorporation.

Show more
Loading
ALMDP
DAX Index
1Y 3Y 5Y 10Y 15Y 20Y
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Dr. Jean-Claude Maurel M.D., MHB
Chairman of the Management Board, CEO & President
No Bio Available
Mr. Mario Alcaraz
Member of the Executive Board & General Secretary
No Bio Available

Contacts

Address
OCCITANIE
Baillargues
L'Oree des Mas Avenue du Golf, Montpellier
Contacts
+33467030396
www.medesispharma.com
sparklesyt

See Also

Summary
ALMDP intrinsic value, competitors valuation, and company profile.
DCF Valuation
ALMDP stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ALMDP stock valuation using valuation multiples.
Wall Street Estimates
ALMDP price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ALMDP stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Back to Top
ALPHA SPREAD
Follow us
Join more than 317,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.